FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely oncology and can be used in mesothelioma treatment. The method consists in monthly subcutaneous introduction to the patient of powdered fibrin solution recovered from the donor's blood clot in a dose 100-600 mg of dry powder per one introduction session.
EFFECT: application of the invention allows for effective cancer therapy by fibrin preparation only without administration of cytostatic agents, radioactive drugs and radioisotopes that ensures reduced complications.
3 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING ANTICARCINOMA SERUM | 1991 |
|
RU2009502C1 |
METHOD FOR BLOOD CELLS RESEARCH | 2015 |
|
RU2614731C1 |
METHOD FOR FIBRIN RESEARCH IN BLOOD CLOT | 2015 |
|
RU2616527C1 |
METHOD OF SINGLE-STAGE INSTALLATION OF INTRAPERITONEAL PORT-SYSTEM IN COMBINATION WITH HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC), INCLUDING INTRAOPERATIVE INSTALLATION OF INTRAPERITONEAL PORT-SYSTEM WITH POSSIBILITY OF FURTHER CARRYING OUT OF NORMOTHERMAL CHEMO-PERFUSION THROUGH PORT SYSTEM | 2020 |
|
RU2740628C1 |
METHOD FOR PREPARING FIBRIN PASTE | 2011 |
|
RU2483076C1 |
METHOD OF TREATMENT OF PATIENTS WITH GENERALIZED TUMOR PROCESSES | 1996 |
|
RU2155590C2 |
METHOD OF TREATING LUNG CANCER | 2010 |
|
RU2463062C2 |
METHOD FOR APPLYING PHOTODYNAMIC THERAPY TO TREAT FOR MALIGNANT TUMORS | 2004 |
|
RU2275945C1 |
METHOD FOR PREPARING FIBRIN PASTE | 2015 |
|
RU2602301C1 |
METHOD FOR PREVENTION OF VENOUS THROMBOEMBOLIA IN PATIENTS WITH CERVICAL CANCER | 2016 |
|
RU2641058C1 |
Authors
Dates
2010-04-20—Published
2008-06-23—Filed